BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2001
View Archived Issues
Baxter expands capacity for plasma-based therapies
Read More
Aastrom Biosciences and the Karmanos Cancer Institute create new cell therapy center
Read More
OraSure Technologies files for approval of rapid HIV test
Read More
Synsorb Biotech receives milestone payment from MDS Proteomics
Read More
Potent and selective NCX inhibitor attenuates reperfusion injury following cerebral ischemia
Read More
EGIS-7229 moves into clinical development
Read More
Marked, long-lasting neuroprotection obtained after i.v. injection of BBB-targeting BDNF conjugate
Read More
Safety of vaccination with ALVAC vector-expressed p53 in primates
Read More
Rubitecan demonstrates potential in HIV therapy
Read More
NeoOncoRx completes acquisition of Neoquin; phase II trials to commence in U.K.
Read More
Nasal immunization of mice with an RSV subunit vaccine protects against viral challenge
Read More
SciClone's lead ISE approved for cancer indication in the Philippines
Read More
FDA Oncologic Drugs Advisory Committee to review Zevalin at upcoming meeting
Read More
Novel inhibitor of cPLA2 with topical and oral antiinflammatory activity
Read More
Hemolink advances through Canadian approval process
Read More
Shire highlights Q2 developments
Read More
Patient enrollment completed in phase I trial of Inex's INX-3280
Read More
Vion's Triapine enters phase II for treatment of leukemia
Read More
Patient enrollment completed in SafeScience phase II pancreatic cancer trial
Read More
VEGF inhibitors useful for angiogenesis-related disorders according to Yamanouchi
Read More
Antibacterial platinum complexes discovered at Asahi Kasei
Read More
Dual 5-HT reuptake inhibitors and 5-HT1A agonists reported by Sumitomo in recent patent
Read More
Sankyo reveals naturally produced MPO inhibitors
Read More
Hydroxamic acid derivatives useful as antimicrobials
Read More
Novel Genzyme intracellular delivery compounds particularly useful in gene therapy
Read More
Neuroprotective agents designed at Nippon Kayaku attenuate paclitaxel-induced damage
Read More